The colors and shapes on the canvas sometimes speak louder than words ever could. She found a way to relinquish control, by choice, and process her grief. Drip painting allowed her to escape thoughts dominated by her diagnosis and treatment to contemplate beauty and wonder. Painting made her realize she could live through challenges and do it in her own authentic way even without having complete control.
“You can have two cups of paint, layered the same way, and the paintings will come out totally different.”
There were days when her emotions were intense or unpredictable and she could watch as the paint poured onto the canvas in wild patterns that mirrored her feelings. But painting always held serendipity, the chance to transform her feelings, and immerse herself in the process.
Her cancer initially responded to the chemotherapy, but in less than a year, it was back. Alisha was also treated with immunotherapy, but it didn’t work for her.
“I hit a roadblock. I didn’t know how to keep fighting.”
But then, her doctor told her about TIVDAK® (tisotumab vedotin-tftv), a prescription medicine to treat adults with advanced cervical cancer. Her doctor explained that unlike traditional chemotherapy, TIVDAK is an antibody-drug conjugate, or ADC, which attacks cells that have a special protein. The special protein, Tissue Factor, is also present on some normal cells. So, TIVDAK can still harm normal cells, which can cause side effects.
TIVDAK can cause serious side effects including eye problems, nerve problems, bleeding problems, lung problems, severe skin reactions, and may harm an unborn baby. Please see the Important Facts about TIVDAK for more information on these and other side effects.
Alisha felt renewed hope, and after discussing all the potential risks and benefits, she made the decision to begin treatment in consultation with her doctor. As a mother, a grandmother, a friend, a stylist, an artist, and so much more—Alisha knew she still had something to say, and with TIVDAK as a treatment option, she found her path forward.